Sign In
Buy IDXX
$564.74
+4.01 (+0.715%)
At Close: Jun 04, 2026
Idexx (IDXX) Soars to 52-Week High, Time to Cash Out?
01:15pm, Monday, 03'rd Aug 2020
Idexx (IDXX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Idexx (IDXX) Soars to 52-Week High, Time to Cash Out?
09:15am, Monday, 03'rd Aug 2020
Idexx (IDXX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zurcher Kantonalbank Zurich Cantonalbank Has $6.42 Million Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
12:28pm, Saturday, 01'st Aug 2020
Zurcher Kantonalbank Zurich Cantonalbank lowered its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 12.2% in the second quarter, according to the company in its most recent 13F filing
IDEXX Laboratories Inc (IDXX) Q2 2020 Earnings Call Transcript
09:30pm, Friday, 31'st Jul 2020
IDXX earnings call for the period ending June 29, 2020.
IDEXX (IDXX) Earnings Beat Estimates in Q2, Margins Rise
09:06pm, Friday, 31'st Jul 2020
IDEXX Laboratories (IDXX) registered strong contribution from its CAG business despite the pandemic-led challenges.
IDEXX (IDXX) Earnings Beat Estimates in Q2, Margins Rise
05:06pm, Friday, 31'st Jul 2020
IDEXX Laboratories (IDXX) registered strong contribution from its CAG business despite the pandemic-led challenges.
Has IDEXX Laboratories (IDXX) Outpaced Other Medical Stocks This Year?
03:30pm, Friday, 31'st Jul 2020
Is (IDXX) Outperforming Other Medical Stocks This Year?
IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q2 2020 Results - Earnings Call Transcript
02:20pm, Friday, 31'st Jul 2020
IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q2 2020 Results - Earnings Call Transcript
Idexx Laboratories (IDXX) Beats Q2 Earnings and Revenue Estimates
11:45am, Friday, 31'st Jul 2020
Idexx (IDXX) delivered earnings and revenue surprises of 43.33% and 9.93%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
At US$374, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely?
11:36am, Friday, 31'st Jul 2020
Let's talk about the popular IDEXX Laboratories, Inc. (NASDAQ:IDXX). The company's shares received a lot of attention...
Has IDEXX Laboratories (IDXX) Outpaced Other Medical Stocks This Year?
11:30am, Friday, 31'st Jul 2020
Is (IDXX) Outperforming Other Medical Stocks This Year?
IDEXX Laboratories Announces Second Quarter Results
10:30am, Friday, 31'st Jul 2020
Reports revenue growth of 3% on a reported basis and 4% on an organic basis driven by Companion Animal Group Diagnostics recurring revenue growth of 7% reported and organic
Idexx Laboratories (IDXX) Beats Q2 Earnings and Revenue Estimates
07:45am, Friday, 31'st Jul 2020
Idexx (IDXX) delivered earnings and revenue surprises of 43.33% and 9.93%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
IDEXX Laboratories Announces Second Quarter Results
06:30am, Friday, 31'st Jul 2020
WESTBROOK, Maine, July 31, 2020 /PRNewswire/ -- Reports revenue growth of 3% on a reported basis and 4% on an organic basis driven by Companion Animal Group Diagnostics recurring revenue growth of 7%
Earnings Scheduled For July 31, 2020
12:00am, Friday, 31'st Jul 2020
Companies Reporting Before The Bell
• Chevron Inc. (NYSE:CVX) is expected to report quarterly loss at $0.92 per share on revenue of $22.10 billion.
• Weyerhaeuser Inc. (...
